The venture's focus on predicting drug resistance mutations aligns with the programme's mission to monitor and combat antimicrobial resistance. The programme's goal to protect public health by disseminating high-quality data also resonates with the venture's aim to improve drug discovery. However, the programme's specifics, such as funding amount and deadline, are not clearly stated.